{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:04:15Z","timestamp":1784347455334,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.msard.2025.106814","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T04:07:52Z","timestamp":1761365272000},"page":"106814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative analysis of plasma proteolytic profiles in multiple sclerosis patients with and without a history of COVID-19"],"prefix":"10.1016","volume":"104","author":[{"given":"Larysa","family":"Kot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Strubchevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Halenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Strubchevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliia","family":"Raksha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Vovk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volodymyr","family":"Melnyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4415-9676","authenticated-orcid":false,"given":"Tetyana","family":"Falalyeyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olexii","family":"Savchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.msard.2025.106814_bib0001","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5662\/wjm.v12.i4.200","article-title":"COVID-19 disease and autoimmune disorders: a mutual pathway","volume":"12","author":"Al-Beltagi","year":"2022","journal-title":"World J. Methodol."},{"issue":"3","key":"10.1016\/j.msard.2025.106814_bib0002","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/ijms22031413","article-title":"Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: pathophysiological and therapeutic perspectives","volume":"22","author":"Behl","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106814_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.755333","article-title":"Multiple sclerosis and SARS-CoV-2: has the interplay started?","volume":"12","author":"Bellucci","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106814_bib0004","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for quantities of utilizing the principle of protein binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.msard.2025.106814_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-0716-4482-9_14","article-title":"Using Zymography to assess circulating matrix metalloproteinase (MMP)-2 and MMP-9 in clinical samples","volume":"2918","author":"Conde-Tella","year":"2025","journal-title":"Methods Mol. Biol."},{"issue":"23","key":"10.1016\/j.msard.2025.106814_bib0006","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.3390\/jcm12237245","article-title":"COVID-19 and the concept of thrombo-inflammation: review of the relationship between immune response, endothelium and coagulation","volume":"12","author":"de Maistre","year":"2023","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.msard.2025.106814_bib0007","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/cells12050684","article-title":"COVID-19 and multiple sclerosis: a complex relationship possibly aggravated by low vitamin D levels","volume":"12","author":"Fernandes de Souza","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.msard.2025.106814_bib0008","doi-asserted-by":"crossref","first-page":"36","DOI":"10.31612\/2616-4868.3.2024.05","article-title":"Coagulation and anticoagulation parameters in multiple sclerosis patients with and without COVID-19","volume":"3","author":"Galenova","year":"2024","journal-title":"Clin. Prevent. Med."},{"key":"10.1016\/j.msard.2025.106814_bib0009","first-page":"144","article-title":"Isolation and partial characterization of serine proteases from jellyfish of the Antarctic region","volume":"11","author":"Halenova","year":"2022","journal-title":"J. Appl. Biol. Biotechnol."},{"issue":"3","key":"10.1016\/j.msard.2025.106814_bib0010","first-page":"46","article-title":"Cytokine profile in multiple sclerosis patients with and without COVID-19","author":"Halenova","year":"2024","journal-title":"Klinichna ta Profilaktychna Medytsyna"},{"issue":"5","key":"10.1016\/j.msard.2025.106814_bib0011","first-page":"221","article-title":"Proteolytic imbalance in plasma of patients with multiple sclerosis following COVID-19","volume":"20","author":"Halenova","year":"2024","journal-title":"Internal Neurol. J."},{"issue":"2","key":"10.1016\/j.msard.2025.106814_bib0012","article-title":"Abnormal proteolytic activity profile in plasma of blood donors according to anti-SARS-CoV-2 IgG titer","volume":"97","author":"Halenova","year":"2024","journal-title":"J. Biol. Res."},{"key":"10.1016\/j.msard.2025.106814_bib0013","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bbi.2023.08.022","article-title":"Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of postacute sequelae of SARS-CoV-2 infection","volume":"114","author":"Hanson","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.msard.2025.106814_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/11772719211013352","article-title":"Multiple sclerosis biomarker discoveries by proteomics and metabolomics approaches","volume":"16","author":"Jafari","year":"2021","journal-title":"Biomark. Insights."},{"issue":"2","key":"10.1016\/j.msard.2025.106814_bib0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.molmed.2023.11.001","article-title":"Redefining metalloproteases specificity through network proteolysis","volume":"30","author":"Kollet","year":"2024","journal-title":"Trends. Mol. Med."},{"key":"10.1016\/j.msard.2025.106814_bib0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","article-title":"Epidemiology of multiple sclerosis: global, regional, national and subnational-level estimates and future projections","volume":"15","author":"Khan","year":"2025","journal-title":"J. Epidemiol. Glob. Health"},{"issue":"3","key":"10.1016\/j.msard.2025.106814_bib0017","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41419-022-04674-3","article-title":"Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.msard.2025.106814_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.871276","article-title":"SARS-CoV-2 and multiple sclerosis: potential for disease exacerbation","volume":"13","author":"MacDougall","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106814_bib0019","series-title":"Atlas of MS: Mapping multiple Sclerosis Around the World","year":"2023"},{"key":"10.1016\/j.msard.2025.106814_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1188816","article-title":"Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond","volume":"14","author":"Motta","year":"2023","journal-title":"Front. Physiol."},{"issue":"9","key":"10.1016\/j.msard.2025.106814_bib0021","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.3390\/ijms26094437","article-title":"Interaction between neutrophils and elements of the blood\u2013Brain barrier in the context of multiple sclerosis and ischemic stroke","volume":"26","author":"Nowaczewska-Kuchta","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106814_bib0022","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4236\/abb.2011.21004","article-title":"Enzyme electrophoresis method in analysis of active components of haemostasis system","volume":"2","author":"Ostapchenko","year":"2011","journal-title":"Adv. Biosci. Biotechnol."},{"issue":"2","key":"10.1016\/j.msard.2025.106814_bib0023","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/cimb45020094","article-title":"Multiple sclerosis: inflammatory and neuroglial aspects","volume":"45","author":"Papiri","year":"2023","journal-title":"Curr. Issues. Mol. Biol."},{"issue":"6","key":"10.1016\/j.msard.2025.106814_bib0024","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.aller.2016.10.011","article-title":"A critical review on serine protease: key immune manipulator and pathology mediator","volume":"45","author":"Patel","year":"2017","journal-title":"Allergol. Immunopathol. (Madr)"},{"key":"10.1016\/j.msard.2025.106814_bib0025","first-page":"144","article-title":"Isolation and partial characterization of serine proteases from jellyfish of the Antarctic region","volume":"11","author":"Raksha","year":"2022","journal-title":"J. Appl. Biol. Biotechnol."},{"key":"10.1016\/j.msard.2025.106814_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1448377","article-title":"Global burden of multiple sclerosis and its attributable risk factors, 1990\u20132019","volume":"15","author":"Safiri","year":"2024","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2025.106814_bib0027","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.3390\/ijms23095162","article-title":"Proteomics in Multiple sclerosis: the perspective of the clinician","volume":"23","author":"Sandi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106814_bib0028","first-page":"38","volume":"87","author":"Savchuk","year":"2021"},{"issue":"14","key":"10.1016\/j.msard.2025.106814_bib0029","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.3390\/ijms22147377","article-title":"Proteomics of multiple sclerosis: inherent issues in defining the pathoetiology and identifying (early) biomarkers","volume":"22","author":"Sen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2025.106814_bib0030","article-title":"Evaluation of proteolytic activity and serine proteases distribution in plasma from patients with bladder cancer","volume":"10","author":"Synelnyk","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"issue":"2","key":"10.1016\/j.msard.2025.106814_bib0031","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106814_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803244","article-title":"Alpha-2-macroglobulin in inflammation, immunity and infections","volume":"12","author":"Vandooren","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2025.106814_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.807149","article-title":"Protein posttranslational signatures identified in COVID-19 patient plasma","volume":"10","author":"Vedula","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.msard.2025.106814_bib0034","article-title":"Proteomic profiling and pathophysiological implications in multiple sclerosis","volume":"12","author":"Wilson","year":"2025","journal-title":"Neurol.: Neuroimmunol. Neuroinflamm."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:38:49Z","timestamp":1784345929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"alternative-id":["S2211034825005565"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106814","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of plasma proteolytic profiles in multiple sclerosis patients with and without a history of COVID-19","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106814"}}